MEDTRONIC ($MDT) posted quarterly earnings results for Q4 2026 on Wednesday, June 3rd. The company reported earnings of $1.55 per share, missing estimates of $1.56 by $0.01. The company also reported revenue of $9,807,000,000, beating estimates of $9,730,481,440 by $76,518,560.
You can see Quiver Quantitative's $MDT stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
MEDTRONIC Insider Trading Activity
MEDTRONIC insiders have traded $MDT stock on the open market 5 times in the past 6 months. Of those trades, 0 have been purchases and 5 have been sales.
Here’s a breakdown of recent trading of $MDT stock by insiders over the last 6 months:
- HARRY SKIP KIIL (EVP & President Cardiovascular) has made 0 purchases and 5 sales selling 52,524 shares for an estimated $5,132,217.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
MEDTRONIC Hedge Fund Activity
We have seen 1,063 institutional investors add shares of MEDTRONIC stock to their portfolio, and 1,170 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- WCM INVESTMENT MANAGEMENT, LLC added 11,265,714 shares (+inf%) to their portfolio in Q1 2026, for an estimated $976,174,118
- CAPITAL WORLD INVESTORS added 9,471,538 shares (+134.6%) to their portfolio in Q1 2026, for an estimated $820,708,767
- BLACKROCK, INC. removed 7,355,311 shares (-6.1%) from their portfolio in Q1 2026, for an estimated $637,337,698
- CAPITAL RESEARCH GLOBAL INVESTORS added 7,353,427 shares (+21.3%) to their portfolio in Q1 2026, for an estimated $637,174,449
- WELLINGTON MANAGEMENT GROUP LLP removed 5,833,795 shares (-43.7%) from their portfolio in Q1 2026, for an estimated $505,498,336
- BOSTON PARTNERS removed 4,707,978 shares (-69.9%) from their portfolio in Q1 2026, for an estimated $407,946,293
- CITADEL ADVISORS LLC removed 4,246,447 shares (-81.2%) from their portfolio in Q1 2026, for an estimated $367,954,632
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
MEDTRONIC Congressional Stock Trading
Members of Congress have traded $MDT stock 2 times in the past 6 months. Of those trades, 0 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $MDT stock by members of Congress over the last 6 months:
- REPRESENTATIVE KEVIN HERN sold up to $50,000 on 03/20.
- REPRESENTATIVE JULIE JOHNSON sold up to $15,000 on 12/18.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API Congress trades endpoint.
MEDTRONIC Analyst Ratings
Wall Street analysts have issued reports on $MDT in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Needham issued a "Buy" rating on 02/17/2026
- Barclays issued a "Overweight" rating on 01/08/2026
- William Blair issued a "Outperform" rating on 01/06/2026
To track analyst ratings and price targets for MEDTRONIC, check out Quiver Quantitative's $MDT forecast page.
MEDTRONIC Price Targets
Multiple analysts have issued price targets for $MDT recently. We have seen 12 analysts offer price targets for $MDT in the last 6 months, with a median target of $108.0.
Here are some recent targets:
- Priya Sachdeva from UBS set a target price of $90.0 on 04/22/2026
- Richard Newitter from Truist Securities set a target price of $95.0 on 04/15/2026
- Anthony Petrone from Mizuho set a target price of $120.0 on 04/13/2026
- Vijay Kumar from Evercore ISI Group set a target price of $106.0 on 04/09/2026
- Joanne Wuensch from Citigroup set a target price of $110.0 on 04/07/2026
- David Toung from Argus Research set a target price of $115.0 on 04/06/2026
- Matt O'Brien from Piper Sandler set a target price of $91.0 on 04/01/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
Check out the Quiver Quantitative API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.
